{"nct_id":"NCT02931539","title":"Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir","status":"COMPLETED","status_verified_date":"2021-09","start_date":"2016-12-22","start_date_type":"ACTUAL","primary_completion_date":"2020-08-17","primary_completion_date_type":"ACTUAL","completion_date":"2020-08-17","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}